Practices
Industries

Lidings Recommended by World Trademark Review 1000

18 February 2021

The rating particularly states that Andrey is “well versed in all aspects of intellectual property and can hammer out favourable outcomes in difficult disputes in the life sciences, fast-moving consumer goods and high-technology spheres” and Boris is “a trusted adviser to numerous pharmaceutical companies on both the patent and trademark sides, and has further know-how in advertising and data protection.

The Russian Government has granted the first compulsory license “in the interests of public security”

03 February 2021

On January 5, 2021 the Decree of the Government of the Russian Federation No. 3718-r dated December 31, 2020 (the Decree) was published. In accordance with the Decree, Pharmasintez JSC, a Russian generic company, has been granted a 1-year compulsory license to use the inventions of the US companies Gilead Sciences Inc. and Gilead Pharmasset LLC protecting Remdesivir subject to a “fair compensation”1.

Lidings Takes Advanced Positions in New Pravo.ru–300 Rating

07 December 2020

Moscow, December 4th 2020. The results of the annual Pravo.ru-300 law firms’ ranking were announced at an awarding ceremony at the Lotte Hotel in Moscow. Based on the analytical research reflecting on the latest tendencies in the country’s legal market, Lidings once again takes top positions in the rating of the legal advisors in Russia.